As shown in Figure 11, both SA and Met treatments were found to be significantly effective in reducing the levels of TGF‐β1, CTGF, and collagen I in comparison to the PCOS rats (p < .01). This evidence concerns the gene TGFB1 and polycystic ovary syndrome.